Genetic testing
113 results
1 - 100
Genetic testing for prevention of severe drug‐induced skin rash- Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
- Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
- Cancer genetic risk assessment for individuals at risk of familial breast cancer
- Effects of communicating DNA‐based disease risk estimates on risk‐reducing behaviours
- Interventions to improve psychosocial well‐being in female BRCA‐mutation carriers following risk‐reducing surgery
- Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease
- Biomedical risk assessment as an aid for smoking cessation
- Strategies for screening for familial hypercholesterolaemia in primary care and other community settings
- Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy
- Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women
- Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer
- Molecular assays for the diagnosis of sepsis in neonates: a diagnostic test accuracy review
- Preconception and antenatal screening for the fragile site on the X‐chromosome
- Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma
- Different communication strategies for disclosing results of diagnostic prenatal testing
- Palliative drug treatments for breathlessness in cystic fibrosis
- Impact of rapid nucleic acid amplification tests for tuberculosis on patient outcomes
- Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease
- Instruments for chorionic villus sampling for prenatal diagnosis
- Screening for colorectal cancer using the faecal occult blood test, Hemoccult
- Interventions for treating painful sickle cell crisis during pregnancy
- Urine tests for Down's syndrome screening
- GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
- Carnitine supplementation for inborn errors of metabolism
- Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less
- The effect of sample site and collection procedure on identification of SARS‐CoV‐2 infection
- First trimester serum tests for Down's syndrome screening
- Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI
- First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening
- First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening
- Dietary exclusions for established atopic eczema
- Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
- Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis
- Disclosing to parents newborn carrier status identified by routine blood spot screening
- Recombinant growth hormone therapy for cystic fibrosis in children and young adults
- Newborn screening for homocystinuria
- Immunotherapy for recurrent miscarriage
- Singing as an adjunct therapy for children and adults with cystic fibrosis
- Biomarkers for diagnosis of Wilson's disease
- Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions
- Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission
- Multi‐domain interventions for the prevention of dementia and cognitive decline
- Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews
- Opioids for chronic non‐cancer pain in children and adolescents
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Decision coaching for people making healthcare decisions
- Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
- Paracetamol (acetaminophen) for chronic non‐cancer pain in children and adolescents
- Newborn screening for galactosaemia
- Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis‐related lung disease
- Notification and support for people exposed to the risk of Creutzfeldt‐Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically)
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Exercise versus airway clearance techniques for people with cystic fibrosis
- Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood
- Chemotherapy for hormone‐refractory prostate cancer
- Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
- Voxel‐based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis
- Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia
- Interventions for promoting participation in shared decision‐making for children and adolescents with cystic fibrosis
- Higher blood pressure targets for hypertension in older adults
- Immunotherapy for metastatic renal cell carcinoma
- Drug treatment for myotonia
- Drugs for preventing red blood cell dehydration in people with sickle cell disease
- Gene therapy for people with hepatocellular carcinoma
- Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I
- Adjuvant Therapy for completely resected Stage II Colon Cancer
- Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
- Physical exercise training for type 3 spinal muscular atrophy
- Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes
- Screening strategies for hypertension
- Inhaled mannitol for cystic fibrosis
- Gene therapy for peripheral arterial disease
- Standard (head‐down tilt) versus modified (without head‐down tilt) postural drainage in infants and young children with cystic fibrosis
- Respiratory muscle training for cystic fibrosis
- Decision aids for people facing health treatment or screening decisions
- Prophylactic anti‐staphylococcal antibiotics for cystic fibrosis